Maintenance therapy of ulcerative colitis in children and teenagers with the Probiotic E-coli strain Nissle 1917

被引：0

作者：

Henker, J ^{[1
]}

Müller, S ^{[1
]}

Niewerth, U ^{[1
]}

Quietzsch, J ^{[1
]}

Dittmer, C ^{[1
]}

Richter, T ^{[1
]}

Schulze, J ^{[1
]}

机构：

[1] Univ Hosp Carl Gustav Carus, Dept Paediat, Dresden, Germany

来源：

PEDIATRIC GASTROENTEROLOGY 2004 | 2004年

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The aim of the present pilot study was to investigate the clinical effects of orally administered E. coli strain Nissle 1917 (EcN) in maintenance therapy of young patients with ulcerative colitis (UC) as compared to the treatment with mesalazine. After one year of observation we could show that relapse rate, clinical activity index (CAI), standard deviation scores (SDS) for height and weight, body-mass index (BMI) as well as efficacy and tolerance of the medication were similar in patients who received mesalazine and patients who changed medication from mesalazine to EcN.

引用

页码：523 / 527

页数：5

共 50 条

[31] The probiotic E-coli Nissle 1917 (Mutaflor®) induces defensins in intestinal epithelial cells:: A novel mechanism of action
Wehkamp, J
Harder, J
Wehkamp-von Meissner, B
Schwichtenberg, L
Fellermann, K
Herrlinger, KR
Schroeder, JM
Stange, EF
GASTROENTEROLOGY, 2002, 122 (04) : A75 - A76
[32] Distinct regulation of cell activation and apoptosis in γ/δ T cells by the probiotic bacterium E-coli Nissle 1917 (EcN)
Guzy, Claudia
Paclik, Daniela
Berndt, Uta
Baumgart, Daniel C.
Wiedenmann, Bertram
Dignass, Axel
Sturm, Andreas
GASTROENTEROLOGY, 2006, 130 (04) : A314 - A314
[33] In vitro and in vivo analysis of the probiotic -: host interaction between E-coli Nissle 1917 and intestinal epithelial cells
Ukena, S
Westendorf, AM
Hansen, W
Rohde, M
Geffers, R
Töpfer, T
Bleich, A
Buer, J
Gunzer, F
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 203 - 204
[34] Probiotic drug therapy with E. coli strain nissle 1917 (EcN):: Results of a prospective study of the records of 3807 patients
Krammer, H. J.
Kaemper, H.
von Buenau, R.
Zieseniss, E.
Stange, C.
Schlieger, F.
CIever, I.
Schulze, J.
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2006, 44 (08): : 651 - 656
[35] Specific detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples
Blum-Oehler, G
Oswald, S
Eiteljoerge, K
Enders, C
Sonnenborn, U
Kruis, W
Hacker, J
GASTROENTEROLOGY, 2003, 124 (04) : A478 - A478
[36] Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
Perez-Berezo, Teresa
Pujo, Julien
Martin, Patricia
Le Faouder, Pauline
Galano, Jean-Marie
Guy, Alexandre
Knauf, Claude
Tabet, Jean Claude
Tronnet, Sophie
Barreau, Frederick
Heuillet, Maud
Dietrich, Gilles
Bertrand-Michel, Justine
Durand, Thierry
Oswald, Eric
Cenac, Nicolas
NATURE COMMUNICATIONS, 2017, 8
[37] Clinical use of E-coli Nissle 1917 in inflammatory bowel disease
Schultz, Michael
INFLAMMATORY BOWEL DISEASES, 2008, 14 (07) : 1012 - 1018
[38] Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV
Ava Behrouzi
Hoora Mazaheri
Sarvenaz Falsafi
Zahra Hoseini Tavassol
Arfa Moshiri
Seyed Davar Siadat
Journal of Diabetes & Metabolic Disorders, 2020, 19 : 597 - 604
[39] Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
Teresa Pérez-Berezo
Julien Pujo
Patricia Martin
Pauline Le Faouder
Jean-Marie Galano
Alexandre Guy
Claude Knauf
Jean Claude Tabet
Sophie Tronnet
Frederick Barreau
Maud Heuillet
Gilles Dietrich
Justine Bertrand-Michel
Thierry Durand
Eric Oswald
Nicolas Cenac
Nature Communications, 8
[40] Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV
Behrouzi, Ava
Mazaheri, Hoora
Falsafi, Sarvenaz
Tavassol, Zahra Hoseini
Moshiri, Arfa
Siadat, Seyed Davar
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (01) : 597 - 604

← 1 2 3 4 5 →